207 related articles for article (PubMed ID: 8220876)
1. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1993 Sep; 110(1):159-62. PubMed ID: 8220876
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
3. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
Gardiner SM; Rakhit T; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1994 Feb; 111(2):589-97. PubMed ID: 7911721
[TBL] [Abstract][Full Text] [Related]
4. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
Li Q; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
[TBL] [Abstract][Full Text] [Related]
5. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
[TBL] [Abstract][Full Text] [Related]
6. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
Widdop RE; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1992 Nov; 107(3):873-80. PubMed ID: 1472980
[TBL] [Abstract][Full Text] [Related]
9. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
10. Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Aug; 118(7):1822-8. PubMed ID: 8842449
[TBL] [Abstract][Full Text] [Related]
11. Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1996 May; 118(2):325-34. PubMed ID: 8735634
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
Picard P; Chrétien L; Couture R
Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular administration of angiotensin II increases heart rate in the conscious trout.
Le Mevel JC; Pamantung TF; Mabin D; Vaudry H
Brain Res; 1994 Aug; 654(2):216-22. PubMed ID: 7987671
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.
Phillips K; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1991 Sep; 104(1):151-8. PubMed ID: 1786509
[TBL] [Abstract][Full Text] [Related]
16. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
[TBL] [Abstract][Full Text] [Related]
17. Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1991 Jan; 102(1):65-72. PubMed ID: 2043932
[TBL] [Abstract][Full Text] [Related]
18. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats.
Widdop RE; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 Mar; 108(3):684-8. PubMed ID: 8467356
[TBL] [Abstract][Full Text] [Related]
20. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
Clark KL; Robertson MJ; Drew GM
Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
